Number of patients
Type of lesions
DES and BMS in-stent restenosis
In-segment maximal area stenosis at 6 months
In-segment Late Lumen Loss at 6 months
TLF at 24 months
TLR at 24 months
De La Torre Cardiovasc Revasc Med. 2019 Jul 23. pii: S1553-8389(19)30433-6
“Clinical efficacy seems to be good and maintained on the very long term.”
In this study, the drug-coated balloon Essential showed a good efficacy in the treatment of ISR (mostly of DES) in terms of OCT and QCA assessment, which appear to be comparable to the provided by other drug-coated balloons well supported by clinical evidence.
Published in Cardiovascular Revascularization Medicine on July 2019.
The publication of ESSENTIAL ISR Trial is available here.
José M. de la Torre Hernandez
Universitary Hospital Marqués de Valdecilla, (Santander, SPA)